Pfizer is +23% over the past year while the S&P 500 is +18%: 4.8 points ahead of the market. 1-year return: +23% (S&P 500 +18%). vs 200-day average: +7.8%, close to trend. RSI (14): 57, neutral. Below its 52-week high: 2.6%.

PFEPfizer

Healthcare

$28.27+23% 1Y

$28.27

$22.4452 weeks$29.03

What is the market doing?

Good

The market is with it: in an uptrend and insiders cluster-buying.

2 good, 1 neutral

TrendUptrendderived · Oct 9, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +8% vs its 200-day average.

Insider conviction+$2.9M (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Multiple insiders bought with their own money, the strongest form of the signal (the 90 days ending Oct 8, 2026).

Short interest2.7% of sharesFINRA · Sep 15, 2026

Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 2.4% since the previous count, down from 2.8% of shares outstanding three months ago.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbetter than 67% of the market

vs 200-day avgbetter than 69% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How PFE is trading

Pfizer is +23% over the past year while the S&P 500 is +18%: 4.8 points ahead of the market.

+23%

1-year return · S&P 500 +18%

vs 200-day average: +7.8%
vs 200-day average · close to trend
RSI (14): 57
RSI (14) · neutral
Below its 52-week high: 2.6%
Below its 52-week high

Sep 17, 2024$19.80 – $29.03 · dashed line: 200-day averageOct 9, 2026

Details›

Last close2026-10-09: $28.27
1 monthS&P 500 +2.7%: +2.2%
1 yearS&P 500 +18%: +23%
5 yearsS&P 500 +88%: −19%
vs 50-day average$27.55: +2.6%
52-week high: $29.03
52-week low: $22.44
Annualised volatility: 24%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08: $2.8M

Calendar-year price return
Year	Return
2026 (year to date)	+17%
2025	+0.65%
2024	−2.2%
2023	−41%
2022	−10%
2021	+67%
2020	+3.1%
2019	−6.9%
2018	+25%
2017	+16%

Average return by calendar month, 2016–2026
Month	Years	Positive	Average
Jan	10	3 of 10	−2.5%
Feb	10	3 of 10	−2.4%
Mar	10	6 of 10	+1.5%
Apr	10	3 of 10	−0.40%
May	10	5 of 10	+2.0%
Jun	10	5 of 10	−1.7%
Jul	11	6 of 11	+3.9%
Aug	11	5 of 11	+0.28%
Sep	11	5 of 11	−0.58%
Oct	11	3 of 11	−1.2%
Nov	10	9 of 10	+6.5%
Dec	10	5 of 10	−0.23%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

Drug Manufacturers, General

The closest names by size in the same industry